Hospital Infection Therapeutics Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2022-2027

1
Hospital Infection Therapeuticses MarketMarket
size, Industry outlook, Market Forecast, Demand
Analysis, Market Share, Market Report 2022-2027
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure

• The Hospital Infection Therapeutics Market Size
  is estimated to reach 14.9 billion by 2027 and
  is poised to grow at a CAGR of 4.5 over the
  forecast period of 2022-2027. Hospital-acquired
  infections (HAIs) are one of the most common
  causes of death worldwide.
• Nosocomial infections or Healthcare-Associated
  Infections are other terms used for it. The risk
  factors for HAI include immunosuppression, older
  age, length of stay in the hospital, multiple
  underlying comorbidities, frequent visits to
  healthcare facilities, mechanical ventilatory
  support, recent invasive procedures, indwelling
  devices, and stay in an intensive care unit
  (ICU).
• Catheter-associated urinary tract infections,
  central line-associated bloodstream infections,
  surgical site infections, ventilator-associated
  pneumonia, hospital-acquired pneumonia, and
  Clostridium difficile infections are the major
  six types of Hospital-acquired infections.

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure

• Key Takeaways
• Geographically, North America held a dominant
  market share in the year 2021, owing to advanced
  health infrastructure and the presence of key
  market players in this region, are the major
  factors responsible for the growth of the
  Hospital Infection Therapeutics Market Share in
  this region.
• The Hospital Infection Therapeutics Market is
  predicted to increase owing to innovative drugs
  launched by key market players and research and
  development. However, the lack of skilled labor
  and the high rate of mortality owing to hospital
  infections may limit market growth over the
  forecast period 2022-2027.

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure
Hospital Infection Therapeutics Market Segment
Analysis- By Drug Type The Hospital Infection
Therapeutics Market based on drug type can be
further segmented into Antibiotics Drugs,
Antifungal Drugs, Antiviral Drugs, and Others.
The Antibiotics Drugs segment held a dominant
market share in the year 2021 and is estimated to
grow with the fastest CAGR rate of 5.1 over the
forecast period 2022-2027. This is owing to the
majority of Hospital Acquired Infections caused
by bacteria. Hence, for any type of
hospital-acquired infection, antibacterial
therapy is the first line of defense.
Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure

• Hospital Infection Therapeutics Market Industry
  Outlook 
• anofi S.A.
• GlaxoSmithKline plc
• AstraZeneca plc
• Merck Co., Inc.
• Pfizer, Inc.
• Actavis plc
• Bayer AG
• Johnson Johnson
• Bristol-Myers Squibb Company
• Cubist Pharmaceuticals, Inc

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Hospital Infection Therapeutics Market -
Forecast(2022 - 2027) Learn More About the
Report _at_ https//www.industryarc.com/Report/173
74/hospital-infection-therapeutics-market.html
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure

• You Can Customize the Report as Per Your Need.
  We have included Some Customization Options
• Company Profile
• Analyst Briefing
• Data Tables
• Key Contacts
• Free Customization
• Purchase Full Report _at_ https//www.industryarc.com
  /purchasereport.php?id17374

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com